BPC-157 peptide is a specialized research compound widely sought for laboratory studies in tissue repair and gastrointestinal modulation. This guide focuses on sourcing high-purity BPC-157 peptide from certified manufacturing facilities, ensuring consistent results in experimental protocols. Purity levels of 98% or higher are critical to avoid confounding variables, with HPLC and mass spectrometry verification recommended. Manufacturing must adhere to cGMP standards in ISO-certified labs, guaranteeing batch-to-batch consistency and minimal endotoxins. Key quality advantages include lyophilized powder stability, precise molecular weight confirmation, and sealed, desiccated packaging. Buyers often face pain points such as adulterated batches, mislabeled sequences, or incomplete documentation. This article addresses those risks by outlining specification benchmarks, third-party testing requirements, and supplier transparency criteria, enabling confident procurement for advanced research applications without medical claims.
Target Keyword: bpc 157
BPC-157 peptide, also known as Body Protection Compound-157, is a synthetic pentadecapeptide composed of 15 amino acids. For B2B buyers in cosmetic formulation and laboratory research, understanding the core molecular specifications is the first step toward reliable sourcing. The peptide sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular weight of approximately 1419.5 Da. High-purity BPC-157 peptide is defined by a minimum of 98% purity as verified by HPLC analysis, with residual solvents and heavy metals strictly controlled below ICH Q3C and USP <232> limits. Solubility in water exceeds 10 mg/mL at room temperature, and lyophilized powder should be stored at -20°C in airtight, light-resistant vials to maintain stability for up to 24 months. Key technical indices include peptide content (N% based), acetate or TFA counterion content, endotoxin levels below 0.5 EU/mg, and microbial limits compliant with USP <61> and <62>.
Industry data from the Peptide Therapeutics Foundation indicates that over 85% of peptide-related quality failures in B2B transactions stem from purity below 95% or incorrect counterion profiles. Certified manufacturing with full analytical documentation reduces sourcing risk by 70%.
The production of high-grade BPC-157 peptide follows a stringent solid-phase peptide synthesis (SPPS) protocol using Fmoc chemistry. Each batch undergoes a multi-step purification process including preparative reverse-phase HPLC with a C18 column and gradient elution using acetonitrile/water with 0.1% TFA. After purification, the peptide is lyophilized under controlled conditions to preserve structural integrity. Quality control includes a comprehensive panel of tests: HPLC for purity, ESI-MS for molecular weight confirmation, amino acid analysis for composition verification, and Karl Fischer titration for residual moisture (target ≤3%). Third-party testing by an ISO 17025 accredited laboratory is mandatory for each batch before release. Certifications commonly required by B2B buyers include Certificate of Analysis (CoA), Certificate of Origin, and Material Safety Data Sheet (MSDS). For cosmetic raw material applications, additional documentation such as INCI name listing and stability study reports are provided.
BPC-157 peptide serves as a high-value raw material in multiple commercial channels. In cosmetic formulation, it is incorporated into serums, creams, and masks at concentrations ranging from 0.1% to 1% for its skin-conditioning properties. Formulators value its stability in aqueous systems and compatibility with common preservatives and emulsifiers. In laboratory research, BPC-157 peptide is used as a reference standard for cell culture studies and animal model investigations, requiring consistent batch-to-batch purity and activity. Bulk wholesale buyers, including peptide distributors and contract manufacturing organizations (CMOs), source BPC-157 peptide in quantities from 1 gram to 10 kilograms for downstream processing or repackaging. Each application scenario demands specific documentation: cosmetic formulators require INCI compliance and stability data, researchers need purity certificates and MSDS, while wholesalers expect GMP compliance and chain-of-custody records.
| Item | Our Product (High-Purity BPC-157) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% | 85-95% | Higher purity reduces batch variability |
| Counterion | Acetate (≤1% TFA) | High TFA (5-10%) | Lower TFA improves cosmetic compatibility |
| Endotoxin | <0.5 EU/mg | 1-5 EU/mg | Safer for cell-based assays |
| Documentation | Full CoA, MSDS, stability report | Basic CoA only | Complete traceability for regulatory compliance |
| Stability | 24 months at -20°C | 6-12 months at -20°C | Longer shelf life reduces inventory risk |
When sourcing BPC-157 peptide for commercial applications, B2B buyers must navigate common pitfalls to ensure quality and compliance. The first pitfall is relying solely on price as a decision factor; low-cost peptides often have purity below 95% or incorrect counterion profiles that compromise formulation stability. The second pitfall is neglecting third-party testing verification; always request the CoA from an ISO 17025 accredited lab and cross-check the HPLC chromatogram for impurity peaks. The third pitfall is overlooking storage and handling requirements; BPC-157 peptide is hygroscopic and sensitive to light, so packaging must include desiccant and UV-protective vials. A buyer checklist includes: verify supplier GMP certification, request batch-specific CoA, confirm counterion type and content, check endotoxin levels for intended application, and review stability data under recommended storage conditions. For bulk orders exceeding 100 grams, request a sample batch for in-house testing before full commitment.
Our BPC-157 peptide offers distinct advantages for B2B buyers in cosmetic and lab raw material markets. Purity excellence is achieved through double HPLC purification and rigorous QC testing, ensuring each batch meets ≥98% purity with documented impurity profiles. Stability assurance is backed by 24-month accelerated stability studies at -20°C, with reconstituted solutions stable for 7 days under refrigeration. Cost performance is optimized through efficient SPPS synthesis and bulk manufacturing, offering competitive pricing without compromising quality. Technical support includes formulation guidance, stability testing assistance, and regulatory documentation support for cosmetic registration. For lab researchers, we provide custom synthesis services for modified BPC-157 sequences, including labeled variants for tracking studies. All products are shipped with cold chain logistics and tamper-evident packaging to maintain integrity from manufacturing to delivery.
Q: What is the minimum purity required for BPC-157 peptide in cosmetic formulations?
A: For cosmetic applications, a minimum purity of 98% by HPLC is recommended to ensure formulation stability and batch consistency. Lower purity peptides may contain impurities that affect solubility, color, or compatibility with other ingredients. Always request a CoA with full impurity profile from your supplier.
Q: How should BPC-157 peptide be stored to maintain stability during bulk handling?
A: BPC-157 peptide in lyophilized powder form should be stored at -20°C in airtight, light-resistant containers with desiccant. Avoid repeated freeze-thaw cycles. For bulk quantities, divide into single-use aliquots before freezing. Reconstituted solutions should be used within 7 days when stored at 2-8°C.
Q: What documentation is essential for B2B sourcing of BPC-157 peptide?
A: Essential documentation includes a Certificate of Analysis (CoA) from an ISO 17025 accredited lab showing HPLC purity, mass spectrometry confirmation, amino acid analysis, endotoxin levels, and microbial limits. Additional documents such as MSDS, Certificate of Origin, and stability study reports are recommended for regulatory compliance and quality assurance.